Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1417836

Investigating the role and regulation of GPNMB in progranulindeficient macrophages

Provisionally accepted
Drew A. Gillett Drew A. Gillett Noelle K. Neighbarger Noelle K. Neighbarger Cassandra Cole Cassandra Cole Rebecca Wallings Rebecca Wallings Malu G. Tansey Malu G. Tansey *
  • University of Florida, Gainesville, United States

The final, formatted version of the article will be published soon.

    Progranulin (PGRN) is a holoprotein that is internalized and taken to the lysosome where it is processed to individual granulins (GRNs). PGRN is critical for successful aging, and insufficient levels of PGRN are associated with increased risk for developing neurodegenerative diseases like AD, PD, and FTD. A unifying feature among these diseases is dysregulation of peripheral immune cell populations. However, considerable gaps exist in our understanding of the function(s) of PGRN/GRNs in immune cells and their role in regulating central-peripheral neuroimmune crosstalk. One of the most upregulated genes and proteins in humans with GRN haploinsufficiency and in aged Grn knock-out (KO) mice is glycoprotein non-metastatic B (GPNMB) but its normal role within the context of immune crosstalk has not been elucidated. We addressed this gap by investigating the regulation of GPNMB in peritoneal macrophages of young WT or Grn KO mice, and discovered that GPNMB is actively increased as a result of insufficient progranulin at a very early age relative to previous reports. Mechanistically, the GPNMB extracellular domain (GPNMB ECD) is shed to negatively regulate inflammatory responses in macrophages and re-addition of PGRN rescues the phenotype. We also found that Microphthalmia-associated Transcription Factor (MITF) is also dysregulated in Grn KO macrophages; however, its nuclear translocation and activity are not required to rescue the immune dysregulation of Grn KO macrophages, suggesting redundancy in the system. These findings highlight the fact that knowledge of early-stage disease mechanism(s) in peripheral populations may inform treatment strategies to delay disease progression at an early, prodromal timepoint prior to development of neuroinflammation and CNS pathology.

    Keywords: progranulin, GPNMB, MITF, macrophage, Inflammation

    Received: 15 Apr 2024; Accepted: 05 Sep 2024.

    Copyright: © 2024 Gillett, Neighbarger, Cole, Wallings and Tansey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Malu G. Tansey, University of Florida, Gainesville, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.